ImmunityBio (IBRX) Cash from Investing Activities Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 30.54% |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | -55.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55.09% |
| Dec 31, 2025 | 62.69% |
| Sep 30, 2025 | -437.49% |
| Jun 30, 2025 | -28.83% |
| Mar 31, 2025 | 27.23% |
| Dec 31, 2024 | 27.47% |
| Sep 30, 2024 | 83.17% |
| Jun 30, 2024 | -90.46% |
| Mar 31, 2024 | -46.10% |
| Dec 31, 2023 | -33.20% |
| Sep 30, 2023 | 34.89% |
| Jun 30, 2023 | -36.86% |
| Mar 31, 2023 | -37.62% |
| Dec 31, 2022 | -59.28% |
| Sep 30, 2022 | -27.39% |
| Jun 30, 2022 | 117.25% |
| Mar 31, 2022 | -52.72% |
| Dec 31, 2021 | -120.08% |
| Sep 30, 2021 | -14.40% |
| Jun 30, 2021 | -21.15% |
| Mar 31, 2021 | 121.76% |
| Dec 31, 2020 | -27.42% |
| Sep 30, 2020 | -116.41% |
| Jun 30, 2020 | -35.46% |
| Mar 31, 2020 | -4.44% |
| Dec 31, 2019 | 45.71% |
| Sep 30, 2019 | 36.34% |
| Jun 30, 2019 | 46.14% |
| Mar 31, 2019 | 42.42% |
| Dec 31, 2018 | 27.90% |
| Sep 30, 2018 | 203.37% |
| Jun 30, 2018 | 235.71% |
| Mar 31, 2018 | 52.88% |
| Dec 31, 2017 | 770.57% |
| Sep 30, 2017 | 239.20% |
| Jun 30, 2017 | 1,341.04% |
| Mar 31, 2017 | 1,901.58% |